Astrana Health, Inc.
ASTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,504 | $1,811 | $1,331 | $3,221 |
| - Cash | $288 | $294 | $288 | $233 |
| + Debt | $472 | $321 | $229 | $201 |
| Enterprise Value | $1,687 | $1,838 | $1,272 | $3,188 |
| Revenue | $2,035 | $1,387 | $1,144 | $774 |
| % Growth | 46.7% | 21.2% | 47.8% | – |
| Gross Profit | $271 | $215 | $199 | $178 |
| % Margin | 13.3% | 15.5% | 17.4% | 23% |
| EBITDA | $142 | $124 | $112 | $101 |
| % Margin | 7% | 8.9% | 9.8% | 13% |
| Net Income | $43 | $61 | $45 | $69 |
| % Margin | 2.1% | 4.4% | 3.9% | 8.9% |
| EPS Diluted | 0.9 | 1.29 | 0.99 | 1.52 |
| % Growth | -30.2% | 30.3% | -34.9% | – |
| Operating Cash Flow | $52 | $68 | $82 | $70 |
| Capital Expenditures | -$8 | -$29 | -$23 | -$19 |
| Free Cash Flow | $44 | $40 | $59 | $51 |